Cite
MLA Citation
Per Lundkvist et al.. “Dapagliflozin once‐daily and exenatide once‐weekly dual therapy: A 24‐week randomized, placebo‐controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes.” Diabetes, obesity & metabolism, vol. 19, no. 1, 2017, pp. 49–60. http://access.bl.uk/ark:/81055/vdc_100039978042.0x00002d